SK
Insider
Steve E. Krognes
DirectorSteve E. Krognes (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Denali Therapeutics Inc. (DNLI). The largest single filing was $1.2M of GH (9,294 sh × $132.51, as filed), executed Jun 4.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.4M
shares × price, as filed
Last traded
Sep 16
Filed Sep 17
Median ADV $437.7M across their filed names
Open performance→Volume by month
Buys $0
Sells $3.9M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
DNLI
Denali Therapeutics Inc.
DNLI · 0 buys · 2 sells
2 filings
GHRecent filings
GHSALE
Guardant Health, Inc.
View filing →
$1.2M6,674 sh across 4 lots
Exec Sep 16
Filed Sep 17 · 5:10 PM ET GHSALE Guardant Health, Inc. View filing → $1.2M
9,294 sh × $132.51
Exec Jun 4
Filed Jun 5 · 5:30 PM ET DNLISALE Denali Therapeutics Inc. View filing → $608K
30,000 sh × $20.25
Exec Dec 31 2024
Filed Jan 3 2025 · 5:30 PM ET DNLISALE Denali Therapeutics Inc. View filing → $871K
30,000 sh × $29.03
Exec Sep 30 2024
Filed Oct 2 2024 · 5:30 PM ET